Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Pancreatic Neoplasms × disitamab vedotin × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 6 Stomach Neoplasms 3 Urinary Bladder Neoplasms 2 Ovarian Neoplasms 2 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Neoplasms 1 Muscle Invasive Bladder Cancer (MIBC) 1 Head and Neck Neoplasms 1 HER2-low Breast Cancer 1 Endometrial Neoplasms 1 Carcinoma, Transitional Cell 1 Carcinoma, Non-Small-Cell Lung 1 Biliary Tract Neoplasms 1 Advanced Breast Cancer 1

Interventions

Gemcitabine 104 130-nm albumin-bound paclitaxel 58 Albumin-Bound Paclitaxel 40 pembrolizumab 34 Fluorouracil 31 Taxes 30 Irinotecan 29 Magnetic Resonance Spectroscopy 27 Specimen Handling 26 Leucovorin 26 Oxaliplatin 25 Cyclophosphamide 20 Biopsy 18 Nivolumab 17 fludarabine 15 Drug Therapy 15 Radiosurgery 14 Radiotherapy 12 Cisplatin 11 Carboplatin 10 Capecitabine 10 irinotecan sucrosofate 9 folfirinox 9 dehydroftorafur 9 Blood Specimen Collection 9 olaparib 8 durvalumab 8 aldesleukin 8 Surveys and Questionnaires 8 Standard of Care 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡